Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on June 25, 2019. The company is an emerging growth company incorporated in California, with common stock (EYES) and warrants (EYESW) trading on NASDAQ. The filing discloses a presentation regarding the Orion Visual Cortical Prosthesis feasibility study at the World Society for Stereotactic and Functional Neurosurgery Conference.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on regulatory disclosure of a scientific presentation and press release rather than financial performance data.
Material Changes
No material financial changes versus a prior period are reported in this document. The primary event is the dissemination of topline data from the Orion feasibility study by principal investigators Nader Pouratian, MD, Ph.D., and Daniel Yoshor, MD.
Guidance, Outlook, and Risks
- Outlook: The Orion system is described as a breakthrough technology intended to provide artificial vision to individuals blind from causes such as glaucoma, diabetic retinopathy, and optic nerve injury.
- Technology: The device converts images from a camera on glasses into electrical pulses transmitted wirelessly to electrodes implanted on the visual cortex.
- Disclaimer: The company explicitly disclaims any obligation to update the presentation materials or reflect events occurring after the date of this report.
- Risks: The filing notes that the information in the presentation is not deemed "filed" for purposes of Section 18 of the Exchange Act unless expressly incorporated by reference.
Investor Verification Checklist
- Verify the specific topline data results from the Orion feasibility study presented in Exhibit 99.1 and 99.2.
- Confirm the current financial status and cash runway of Second Sight Medical Products, Inc., as this 8-K contains no financial statements.
- Review the regulatory pathway and FDA status for the Orion Visual Cortical Prosthesis.
- Check for any subsequent updates or press releases regarding the study results post-June 25, 2019.